science
Wired Science
2026-10-24
Personalized mRNA Vaccine Shows Promise Against Melanoma Recurrence
A new Phase 3 trial indicates that a personalized mRNA cancer vaccine can reduce the risk of melanoma recurrence by over 40 percent.